Publications from MoBa-Corona, NorFlu-Corona, The Senior Cohort and Young Adult Cohort
Article
|Updated
Here is an overview of publications and reports from MoBa-Corona, NorFlu-Corona, The Senior Cohort and Young Adult Cohort.
Peer-reviewed publications
Adverse events following vaccination
- Lill Trogstad, Anna Hayman Robertson, Siri Mjaaland, Per Magnus. Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study. Vaccine; 2021. Sep 24;39(40):5854-5857. doi: 10.1016/j.vaccine.2021.08.055. Epub 2021 Aug 31. PMID: 34479760; PMCID: PMC8406020.
- Lill Trogstad, Ida Laake, Anna H. Robertson, Siri Mjaaland, Ida H. Caspersen, Lene K. Juvet, Per Magnus, Kristine Blix, Berit Feiring. Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination. 2023. Vaccine, 41(36), 5271-5282. doi:https://doi.org/10.1016/j.vaccine.2023.06.088
- Lill Trogstad, Lene Juvet, Berit Feiring, Kristine Blix. Covid-19 vaccines and menstrual changes. BMJ Medicine 2022;1:e000357. doi: 10.1136/bmjmed-2022-000357
- Ida Henriette Caspersen, Lene K Juvet, Berit Feiring, Ida Laake, Anna Hayman Robertson, Siri Mjaaland, Per Magnus and Lill Trogstad. Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: population-based cohort study in Norway. Vaccine; 2022. doi: 10.1016/j.vaccine.2022.11.068
- Kristine Blix, Ida Laake, Lene Juvet, Anna Hayman Robertson, Ida Henriette Caspersen, Siri Mjaaland, Siri N Skodvin, Per Magnus, Berit Feiring, Lill Trogstad. Unexpected vaginal bleeding and COVID-19 vaccination in non-menstruating women. Science Advances. Sep 2023. DOI: 10.1126/sciadv.adg1391
Vaccine effectiveness
- Ida Laake, Siri N Skodvin, Kristine Blix, Ida Henriette Caspersen, Håkon K Gjessing, Lene K Juvet, Per Magnus, Siri Mjaaland, Anna H Robertson, Jostein Starrfelt, Lill Trogstad, Berit Feiring. Effectiveness of mRNA booster vaccination against mild, moderate, and severe COVID-19 caused by the Omicron variant in a large, population-based, Norwegian cohort. Journal of Infectious Diseases;2022. doi: 10.1093/infdis/jiac419
Immune responses
- Mukherjee, R., Eggesbø, L. M., Wolf, A.-S., Kjønstad, I. F., Solum, G., Ravussin, A., Bhandari, S., Robertson, A. H., Magnus, P., Trogstad, L., Kristoffersen, A. B., Nygaard, U. C., & Mjaaland, S. (2024). Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly. npj Vaccines, 9(1), 238. https://doi.org/10.1038/s41541-024-01028-2
- Anthony Ravussin, Anna Hayman Robertson, Asia-Sophia Wolf, Kristine Blix, Ingrid Fadum Kjønstad, Guri Solum, Berit Feiring et.al. Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in healthy seniors. Lancet Healthy Longevity; 2023. doi: 10.1016/S2666-7568(23)00055-7
- Asia-Sophia Wolf, Anthony Ravussin, Marton König, Mathias H. Øverås, Guri Solum, Ingrid Fadum Kjønstad et.al. T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis. JCI Insight; 2023. doi: 10.1172/jci.insight.165111
- Bjørlykke KH, Ørbo HS, Tveter AT, Jyssum I, Sexton J, Tran TT, Christensen IE, Kro GB, Kvien TK, Jahnsen J, Munthe LA, Chopra A, Warren DJ, Mjaaland S et.al. Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study. Lancet Rheumatol. 2023 Jan;5(1):e36-e46. doi: 10.1016/S2665-9913(22)00330-7.
- Hassen Kared, Asia-Sophia Wolf, Amin Alirezaylavasani, Anthony Ravussin, Guri Solum, Trung The Tran, Fridtjof Lund-Johansen, John Torgils Vaage et.al. Immunity in Omicron SARS-CoV-2 breakthrough COVID-19 in vaccinated adults. Nat Commun; 2022;. doi: 10.1038/s41467-022-31888-y
- Syversen SW, Jyssum I, Tveter AT, Sexton J, Christensen IE, Tran TT, Bjørlykke KH, Mjaaland S et.al. Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy. RMD Open. 2022 Nov;8(2):e002417. doi: 10.1136/rmdopen-2022-002417. PMID: 36328399.
- Christensen IE, Jyssum I, Tveter AT, Sexton J, Tran TT, Mjaaland S, Kro GB et.al. The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study. BMC Med. 2022 Oct 5;20(1):378. doi: 10.1186/s12916-022-02587-8. PMID: 36199139.
- Syversen SW, Jyssum I, Tveter AT, Tran TT, Sexton J, Provan SA, Mjaaland S, Warren DJ et.al. Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy. Arthritis Rheumatol. 2022 Aug;74(8):1321-1332. doi: 10.1002/art.42153. Epub 2022 Jun 29
- Jyssum I, Kared H, Tran TT, Tveter AT, Provan SA, Sexton J et.al. Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. Lancet Rheumatol. 2022 Mar;4(3):e177-e187. doi: 10.1016/S2665-9913(21)00394-5. Epub 2021 Dec 23
- Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA et.al. Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. Eur Heart J. 2021 Oct 14;42(39):4064-4072. doi: 10.1093/eurheartj/ehab506.PMID: 34405870
Infection and Long covid
- Caspersen IH, Trogstad L, Galanti MR, Karvonen S, Peña S, Shaaban AN Shaaban, SE Håberg, Per Magnus. Current tobacco use and SARS-CoV-2 infection in two Norwegian population-based cohorts. BMC Public Health. 2023;23(1):846. org/10.1186/s12889-023-15822-5
Infection and tobacco
- Caspersen IH, Trogstad L, Galanti MR, Karvonen S, Peña S, Shaaban AN Shaaban, SE Håberg, Per Magnus. Current tobacco use and SARS-CoV-2 infection in two Norwegian population-based cohorts. BMC Public Health. 2023;23(1):846. org/10.1186/s12889-023-15822-5
Seroprevalence
- TT Tran, EB Vaage, A Mehta, A Chopra, L Tietze, A Kolderup et.al. Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants. npj Vaccines, 7(1), 174. doi:10.1038/s41541-022-00586-7
-
Tunheim, G., Fossum, E., Robertson, A. H., Rø, G. Ø. I., Chopra, A., Vaage, J. T., Vikse, E. L., Kran, A.-M.B., Magnus, P., Trogstad, L., Mjaaland, S., Hungnes, O., & Lund-Johansen, F. (2024). Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults. BMC Infectious Diseases, 24(1), 841. doi.org/10.1186/s12879-024-09670-w
Work situation and life satisfaction
- Ellen Øen Carlsen, Ida H Caspersen, Helga Ask, Ragnhild Eek Brandlistuen, Lill Trogstad, Per Magnus. Association between work situation and life satisfaction during the COVID-19 pandemic: prospective cohort study in Norway. BMJ Open; 2022. 12(4), e049586. doi:10.1136/bmjopen-2021-049586
- Ingibjörg Magnúsdóttir, Anikó Lovik, Anna Bára Unnarsdóttir, Daniel McCartney, Helga Ask, Kadri Kõiv et.al. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study, Lancet Public Health;2022. doi: 10.1016/S2468-2667(22)00042-1
- Bjørn-Atle Reme, Jonathan Wörn, Vegard Skirbekk. Longitudinal evidence on the development of socioeconomic inequalities in mental health due to the COVID-19 pandemic in Norway, Sci Rep;2022. doi: 10.1038/s41598-022-06616-7
- Unnarsdóttir, A. B., et al. Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations, Int J Epidemiol;2022. doi: 10.1093/ije/dyab234
- Lu L, Hannigan LJ, Brandlistuen RE, Nesvåg R, Trogstad L, Magnus P, Unnarsdóttir AB, Valdimarsdóttir UA, Andreassen OA, Ask H. Mental Distress Among Norwegian Adults During the COVID-19 Pandemic: Predictors in Initial Response and Subsequent Trajectories. Int J Public Health. 2023 Oct 25;68:1606164. doi: 10.3389/ijph.2023.1606164
- Lovik A, González-Hijón J, Hoffart A, Fawns-Ritchie C, Magnúsdóttir I, Lu L, Unnarsdóttir AB et.al. Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients - an observational study of five cohorts across four countries. Lancet Reg Health Eur. 2023 Sep 4;33:100733. doi: 10.1016/j.lanepe.2023.100733
Other reports and preprints
Seroprevalence
Symptoms and testing for SARS-CoV-2
- Weekly reports, week 20, 2020- week 20, 2022. Ukerapporter om covid-19, influensa og andre luftveisinfeksjoner - FHI
Adherence to recommendations
- Carlsen EØ, Caspersen IH, Trogstad L, Gjessing H, Magnus P. Public adherence to governmental recommendations regarding quarantine and testing for COVID-19 in two Norwegian cohorts. Preprint;2021. org/10.1101/2020.12.18.20248405
Other peer-reviewed publications
Controls and clinical cohorts
- Wolf AS, Bjørlykke KH, Ørbo HS, Bhandari S, Solum G, Kjønstad IF, Jyssum I, Nygaard UC, Kristoffersen AB, Christensen IE, Josefsson SE, Lund KP, Chopra A, Osen JR, Chaban V, Tveter AT, Sexton J, Kvien TK, Jahnsen J, Haavardsholm EA, Grødeland G, Vaage JT, Provan SA, Kared H, Lund-Johansen F, Munthe LA, Syversen SW, Goll GL, Jørgensen KK, Mjaaland S. T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study. EBioMedicine. 2024 Sep 10;108:105317. doi: 10.1016/j.ebiom.2024.105317. Epub ahead of print. PMID: 39260039; PMCID: PMC11416219.
- Bjørlykke, Ørbo, Tveter, Jyssum, Sexton, Tran et al. Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study. Lancet Rheumatology; 2023. Doi: 10.1016/S2665-9913(22)00330-7
- Holm S et al. Immune complexes, innate immunity and NETosis in ChAdOx1 vaccine induced thrombocytopenia. Eur Heart J 2021; doi:10.1093/eurheartj/ehab506
- Syversen SW et al. Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory disease on immunosuppressive therapy. RDM Open 2022; doi: 10.1136/rdmopen-2022-002417
- Syversen SW et al. Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy. Arthritis & Rheumatology; 2022. doi: 10.1002/art.42153
- Christensen IE et al. The persistence of anti-spike antibodies following two SARS-COV-2 vaccine doses in patients on immunosuppressive therapy compared to heathy controls – a prospective cohort study. BMC Med 2022 doi:10.1186/s12916-022-02587-8
- Jyssum I, Kared H, Tran TT, Tveter AT, Provan SA, Sexton J. Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. Lancet Rheumatology;2022, org/10.1016/S2665-9913(21)00394-5
- Myklebust CV, York JP, Lund KP, Grødeland G, Tveita A, Nisen-Meyer LS et.al. Preexisting Cross-Reactive T Cells are Boosted and Comprise Significant Immunity in COVID-19 Recovered Patients. EuropePMC; 2021.
- Køning et al. Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders. Preprint;2021. org/10.1101/2021.10.15.21264977
